GSK Gets $3.5M Verdict In Norvir Antitrust Case
Abbott Laboratories must pay GlaxoSmithKline PLC $3.5 million for raising the price of HIV drug Norvir despite a deal that let GSK include it in a drug cocktail, but Abbott did...To view the full article, register now.
Already a subscriber? Click here to view full article